IP Library Granted Patent US 11,298,489
Granted Patent B2
US 11,298,489 · App. 16/428,544 · Granted Apr 12, 2022

Methods and devices for passive residual lung volume reduction and functional lung volume expansion

Inventors: Nikolai Aljuri (Hillsborough, CA); Rodney C. Perkins (Woodside, CA); Ryan Olivera (Granite Bay, CA); Hoang Nguyen (San Jose, CA); Srikanth Radhakrishnan (Cupertino, CA); Niyazi Beyhan (Santa Clara, CA)
Assignee: Pulmonx Corporation
A61M16/0434A61B1/2676A61B5/0084A61B5/08A61B5/4836A61B17/12104A61B17/12136A61M16/0003A61M16/208A61F2002/043A61M16/0436A61M25/10A61M2016/003A61M2016/0027A61M2025/1052A61M2202/0208A61M2205/3334A61M2207/10Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,298,489
App. No.
16/428,544
Granted
Apr 12, 2022
Kind
B2
Abstract

The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.

Claims (4)

1. A diagnostic catheter comprising:

a catheter body having a distal end, a proximal end, and a lumen extending from the distal end to the proximal end, wherein at least a distal portion of the catheter body is adapted to be advanced through the airways of the lung; and

a transparent expandable member disposed near the distal end of the catheter body, wherein the transparent expandable member is adapted to be expanded in an airway leading to a lung compartment, wherein a proximal end of the transparent expandable member is attached to an outer surface of the catheter body and a distal portion of the transparent expandable member is attached to an inner surface of the lumen such that the transparent expandable member forms the wide angle lens.

2. The diagnostic catheter of claim 1 , wherein the proximal end of the transparent expandable member is attached circumferentially to the outer surface of the catheter body and the distal portion of the transparent expandable member is attached circumferentially to the inner surface of the lumen.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2019
From: ALJURI, NIKOLAI; PERKINS, RODNEY C.; OLIVERA, RYAN; NGUYEN, HOANG; RADHAKRISHNAN, SRI; BEYHAN, NIYAZI
To: PULMONX
Reel/Frame 051175/0337 →
MERGER AND CHANGE OF NAME Recorded Dec 4, 2019
From: PULMONX; PULMONX CORPORATION
To: PULMONX CORPORATION
Reel/Frame 051175/0422 →